武栋成 - 武汉大学 - 基础医学院

个人简介

学习经历： 1982.09-1987.07: 中国、湖北医学院医学系本科毕业获医学学士学位 1990.09-1993.07: 中国、湖北医科大学研究生毕业获医学硕士学位 1998.09-2000.10: 中国香港、香港科技大学生物化学系研究生毕业获哲学硕士学位 2002.09 -2005.07: 中国、武汉大学研究生毕业获医学博士学位主要工作经历与任职： 2009.06-至今：中国、武汉大学基础医学院，教授、博士生导师 2012.06-至今：武汉汉密顿生物科技股份有限公司，董事长、总经理、公司首席科学家 2014.01-2015.12：湖北第二师范学院化学与生命科学学院，院长 2005.06-2009.06：加拿大、McMaster大学，博士后、研究科学家 2001.04-2005.05：加拿大、McMaster大学医学院访问学者 1993.07-1998.08：中国、湖北医科大学助教、讲师

个人简介

研究领域

1.干细胞移植治疗脊髓损伤的基础与临床研究 2.糖尿病肾病是糖尿病最主要的微血管并发症 3.间充质干细胞治疗急慢性肾病（肾损伤）、骨性关节炎等难治性疾病的基础与临床前研究，动物实验证明了间充质干细胞移植治疗骨性关节炎、急慢性肾病的疗效，相关研究项目正积极向国家相关部委进行干细胞临床研究

研究领域

专业：

研究方向：

研究领域和兴趣：

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Ma Y, Yuan S, Tian X, Lin S, Wei S, Hu T, Chen S, Li X, Chen S, Wu D*, Wang M*, Guo D. ABIN1 inhibits HDAC1 ubiquitination and protects it from both proteasome- and lysozyme-dependent degradation. J Cell Biochem., 2018, 119 (4):3030-3043. (*通讯作者） 2. Cao J, Ma Y, Yao W, Zhang X, Wu D*. Retinoids Regulate Adipogenesis Involving the TGFβ/SMAD and Wnt/β-Catenin Pathways in Human Bone Marrow Mesenchymal Stem Cells. Int J Mol Sci.，2017, 15, 18(4). pii: E842. doi: 10.3390/ijms18040842. (*通讯作者） 3. Hu Z, Zhang X, Yang H, Qin S, Liu Y, Xiong W, Yuan B, Li L, Yao W*, Wu D*.Alterations in expression levels of genes in p53‑related pathways determined using RNA‑Seq analysis in patients with breast cancer following CIK therapy. Oncol Lett., 2017, 14(6):7917-7922. (*通讯作者） 4. Zhang XY, Zou L, Yu D, Zhang T, Yao WQ, Bing Yuan B, Xiong W, Wu D C*, Cheng H. Identification of the eEF1A2 expression level by RNA-seq analysis in doxorubicin-tolerant K562 cell lines. Int J Exp Pathol,2016,9(6):6371-6377. (*通讯作者） 5. Yao WQ*, Hu QY*, Ma YH, Xiong WP, Wu T T, Cao J and Wu DC#. Human adipose-derived mesenchymal stem cells repair cisplatin-induced acute kidney injury through ant-iapoptotic pathways. Exp Ther Med. DOI: 10.3892/etm.2015.2505 (#通讯作者) 6.Wang B, Xiong SF, Hua QQ, Chen C, Hua Liao H, Chen L, Yao WQ, Wu DC, Tao ZZ*.Tissue factor is strongly expressed in pericarcinomatous tissue in patients with laryngeal carcinoma. Int J Clin Exp Pathol., 2015, 8(10):13719-13724. (*通讯作者) 7. Mehling BM, Quartararo L, Manvelyan M*, Wang P, Wu DC. Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation. CellR4, 2015，3 (2): e1562. (*通讯作者) 8. Mehling BM, Quartararo L, Manvelyan M*, Wang P and Wu DC. Evaluation of Immune response to Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation. J Stem Cell Res Ther 2015, 5:297. doi:10.4172/2157-7633.1000297(*通讯作者)

近期论文

1.Ma Y, Yuan S, Tian X, Lin S, Wei S, Hu T, Chen S, Li X, Chen S, Wu D*, Wang M*, Guo D. ABIN1 inhibits HDAC1 ubiquitination and protects it from both proteasome- and lysozyme-dependent degradation. J Cell Biochem., 2018, 119 (4):3030-3043. (*通讯作者）  2. Cao J, Ma Y, Yao W, Zhang X, Wu D*. Retinoids Regulate Adipogenesis Involving the TGFβ/SMAD and Wnt/β-Catenin Pathways in Human Bone Marrow Mesenchymal Stem Cells. Int J Mol Sci.，2017, 15, 18(4). pii: E842. doi: 10.3390/ijms18040842. (*通讯作者）  3. Hu Z, Zhang X, Yang H, Qin S, Liu Y, Xiong W, Yuan B, Li L, Yao W*, Wu D*.Alterations in expression levels of genes in p53‑related pathways determined using RNA‑Seq analysis in patients with breast cancer following CIK therapy. Oncol Lett., 2017, 14(6):7917-7922. (*通讯作者）  4. Zhang XY, Zou L, Yu D, Zhang T, Yao WQ, Bing Yuan B, Xiong W, Wu D C*, Cheng H. Identification of the eEF1A2 expression level by RNA-seq analysis in doxorubicin-tolerant K562 cell lines. Int J Exp Pathol,2016,9(6):6371-6377. (*通讯作者）  5. Yao WQ*, Hu QY*, Ma YH, Xiong WP, Wu T T, Cao J and Wu DC#. Human adipose-derived mesenchymal stem cells repair cisplatin-induced acute kidney injury through ant-iapoptotic pathways. Exp Ther Med. DOI: 10.3892/etm.2015.2505 (#通讯作者)  6.Wang B, Xiong SF, Hua QQ, Chen C, Hua Liao H, Chen L, Yao WQ, Wu DC, Tao ZZ*.Tissue factor is strongly expressed in pericarcinomatous tissue in patients with laryngeal carcinoma. Int J Clin Exp Pathol., 2015, 8(10):13719-13724. (*通讯作者)  7. Mehling BM, Quartararo L, Manvelyan M*, Wang P, Wu DC. Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation. CellR4, 2015，3 (2): e1562. (*通讯作者)  8. Mehling BM, Quartararo L, Manvelyan M*, Wang P and Wu DC. Evaluation of Immune response to Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation. J Stem Cell Res Ther 2015, 5:297. doi:10.4172/2157-7633.1000297(*通讯作者)